Short answer · Medically reviewed summary · Last updated: 2026-04-06
The most promising advances in Phyllodes tumor research currently focus on identifying molecular drivers and targeted therapies for malignant cases, as traditional surgical excision remains the standard of care for most patients. Current Research Directions and Molecular Insights Recent genomic studies have significantly expanded our understanding of the pathogenesis of Phyllodes tumor. Research increasingly highlights the role of the MED12 gene mutation in benign and borderline cases, while malignant Phyllodes tumor cases are often associated with mutations in TERT, TP53, and KMT2D.
7 people with Phyllodes tumor have shared their first-person experience on this question at DiseaseMaps.
What are the latest advances in Phyllodes tumor?
Latest advances in Phyllodes tumor: recent research, treatments in development and what they could mean, with sources.
The most promising advances in Phyllodes tumor research currently focus on identifying molecular drivers and targeted therapies for malignant cases, as traditional surgical excision remains the standard of care for most patients.
Current Research Directions and Molecular Insights
Recent genomic studies have significantly expanded our understanding of the pathogenesis of Phyllodes tumor. Research increasingly highlights the role of the MED12 gene mutation in benign and borderline cases, while malignant Phyllodes tumor cases are often associated with mutations in TERT, TP53, and KMT2D. These findings are shifting the landscape toward precision medicine, where researchers are investigating whether these specific genetic signatures can predict recurrence risk or inform targeted drug selection.
Clinical Trials and Emerging Therapies
While there are currently no FDA-approved systemic therapies specifically indicated for Phyllodes tumor, clinical investigation is ongoing. Researchers are exploring the use of anti-angiogenic agents and immunotherapy in patients with metastatic or unresectable disease. Because these tumors are rare, clinical trials often group them within broader sarcoma research frameworks. Patients and caregivers can search for active studies on ClinicalTrials.gov by using the term "Phyllodes tumor" to identify trials evaluating novel combinations of chemotherapy or targeted inhibitors.
Diagnostic Tools and Collaboration
New diagnostic efforts are centered on refining immunohistochemical markers to better distinguish between benign, borderline, and malignant Phyllodes tumor specimens, which is critical for determining the necessary surgical margins. Major cancer research centers and sarcoma-focused consortia are currently leading the push for international data-sharing initiatives. These collaborations are essential for building the large datasets required to understand this rare condition more thoroughly.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- National Cancer Institute (NCI) Physician Data Query (PDQ) on Adult Soft Tissue Sarcoma
Phyllodes tumors are relatively rare. Therefore there is little information
available, even for doctors. In order to get more attention for this special breast
tumor, a group of volunteers involved has set up a website. www.phyllodestumor.org , which is part of www.phyllodes.net
The available information so far about Phyllodes has been spread over various sites,
trade journals and support groups. For www.Phyllodestumor.nl, volunteers
have brought all available information in one place.
The site has been set up to share the knowledge about this rare tumor with both
patients and physicians. On www.phyllodestumor.org articles and information about this rare form of breast tumors are readily available.
In addition, the site provides information about the different forms, treatment
methods, prognoses and risks of Phyllodes tumors.
The content of the site was developed in collaboration with breast cancer surgeon Mr. F. van Duijnhoven (AVL A’dam).
Launch: Thursday 6 September 2018 4 pm
Antoni van Leeeuwenhoek hospital
Plesmanlaan 121
1066 CX Amsterdam
For more information about Phyllodes tumors, please visit www.phyllodestumor.org
Posted Aug 29, 2018 by Phyllodesfoundation.com
Posted Nov 26, 2017 by Sabrina 2500
Posted May 6, 2018 by Marie 2500
Chemotherapy is recently being explored for preventing future metastasis in high grade malignant tumors. The chemo drugs I am having are Epirubicin and Ifosfamide with Mesna.
Posted Apr 21, 2019 by Ashlie 1800
Minimum margins of 1cm are standard but not always adhered to. Some suggest chemo and rads but most agree they provide little to no benefit. Standard treatment for a MPT is mastectomy with or without reconstruction.
Posted Aug 10, 2020 by Simone Lovett 2550
Posted Sep 26, 2020 by Lucy 3570
